Results 91 to 100 of about 1,856,875 (191)

Serum soluble urokinase plasminogen activator receptor in adolescents: interaction of chronic pain and obesity

PAIN Reports, 2020
:. Introduction:. Obesity in adolescents is increasing in frequency and is associated with short-term and long-term negative consequences that include the exacerbation of co-occurring chronic pain. Objective:. To determine whether the interaction between
Hershel Raff, Jonathan M. Phillips, Pippa M. Simpson, Steven J. Weisman, Keri R. Hainsworth   +4 more
doaj   +1 more source

Influence of Protein Glycosylation on the Measurement of Soluble Urokinase Plasminogen Activator Receptor

The Journal of Applied Laboratory Medicine
Abstract Background Elevated concentrations of the glycoprotein soluble urokinase plasminogen activator receptor (suPAR) predict worse cardiovascular disease (CVD) outcomes.
Jaya Montecillo, Richard W Troughton, A Mark Richards, Christopher J Pemberton, Janice Chew-Harris   +4 more
openaire   +2 more sources

Engineering CAR‐Macrophages With Advanced Delivery Systems for Tissue Repair

Advanced Science, Volume 13, Issue 51, 14 September 2026.
This review highlights how engineered macrophages equipped with chimeric antigen receptors (CAR) guide tissue repair by recognizing disease‐related targets, clearing harmful cells, and reshaping local immune environments. It summarizes macrophage biology, CAR design, delivery platforms, and functionalization strategies, and discusses emerging ...
Yixin Zhang, Jintian Yu, Liang Yuan, Ziliang Fu, Yiming Yao, Lingna Chen, Shixiong Chen, Aikemu Ainiwaer, Xiaolin Cui   +8 more
wiley   +1 more source

Abstract 16154: Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes

, 2012
Introduction: Soluble urokinase plasminogen activator receptor (suPAR) is an emerging inflammatory and immune biomarker. Recent studies have demonstrated a positive association of suPAR with incide..
Al Kassem, Hatem, Ghasemzadeh, Nima, Bhatia, Neal K., Le, Ngoc-Anh, Manocha, Pankaj, Thorball, Christian W., Hammadah, Muhammad, Wilmot, Kobina, Lerakis, Stamatios, Kabbany, Mohammad Tarek, Khayata, Mohamed, Yendamuri, Revanth, Quyyumi, Arshed A., Patel, Riyaz S., Veledar, Emir, Alradawi, Suliman, Halista, Michael M, Tahhan, Ayman Samman, Sperling, Laurence S., Eapen, Danny J., Asfari, Mohammad M, Pielak, Tomasz   +21 more
core   +1 more source

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction

NeuroMolecular Medicine
Abstract The inflammatory response is essential for host defense, but its persistence can lead to chronic systemic inflammation (CSI). Soluble urokinase-type plasminogen activator receptor (suPAR) has emerged as a reliable biomarker of CSI because elevated levels consistently indicate the presence and progression of chronic disease as
Victoria Linden de Rezende, Khiany Mathias, Lucineia Gainski Danielski, Tatiana Barichello, Fabricia Petronilho   +4 more
openaire   +2 more sources

Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration

BMEMat, Volume 4, Issue 3, September 2026.
The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang, Yu‐zhu Wang, Yi‐fei Wang, Que Bai, Jia‐xin Hao, Zhi‐ting Li, Xiao‐qing Cao, Yu Wei, Yue Feng, Ji‐hua Chen, Franklin R. Tay, Rui‐bing Wang, Jun‐ting Gu, Li‐na Niu   +13 more
wiley   +1 more source

Soluble urokinase plasminogen activator receptor—A valuable biomarker in systemic lupus erythematosus?

Clinica Chimica Acta, 2015
Systemic lupus erythematosus (SLE) is a potentially severe autoimmune condition with an unpredictable disease course, often with fluctuations in disease activity over time. Long term inflammation and drug-related side-effects may subsequently lead to permanent organ damage, a consequence which is intimately connected to decreased quality of life and ...
Helena Enocsson, Christopher Sjöwall, Jonas Wetterö   +2 more
openaire   +4 more sources

Natural Compounds Targeting Oncogenic Signaling Networks in Glioblastoma: Molecular Mechanisms, Translational Advances, and Clinical Perspectives

Brain and Behavior, Volume 16, Issue 9, September 2026.
Glioblastoma (GBM) is a highly aggressive brain tumor with a poor prognosis, driven by abnormal signaling pathways that promote growth and resistance to treatment. Conventional therapies are inadequate, highlighting the need for novel multitargeted approaches.
Mehrukh Zehravi, Md Abul Hassan, Md. Al Amin, Sherouk Hussein Sweilam, Jeetendra Kumar Gupta, Ramenani Hari Babu, Pericharla Venkata Narasimha Raju, Krishna Vamsi Kandimalla, Phanindra Erukulla, Patibandla Jahnavi, Rajeshwar Vodeti, Abdul Ajeed Mohathasim Billah, Safia Obaidur Rab, Sharuk L. Khan   +13 more
wiley   +1 more source

sj-jpg-1-bmi-10.1177_11772719221081789 – Supplemental material for Utilization of Prognostic Biomarker Soluble Urokinase Plasminogen Activator Receptor in the Emergency Department: A Tool for Safe and More Efficient Decision-making

, 2022
Supplemental material, sj-jpg-1-bmi-10.1177_11772719221081789 for Utilization of Prognostic Biomarker Soluble Urokinase Plasminogen Activator Receptor in the Emergency Department: A Tool for Safe and More Efficient Decision-making by Ria M Holstein ...
Marja T Mäkinen (12226739), Ria M Holstein (12226736), Johanna M Kaartinen (12226745), Maaret K Castrén (12226742)   +3 more
core   +1 more source

Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases

Chronic Diseases and Translational Medicine, 2017
Atherosclerosis (AS) is a systemic chronic disease affecting both the coronary and cerebral arteries. Inflammation plays a key role in the initiation and progression of AS, and numerous inflammatory factors have been proposed as potential biomarkers ...
Jun-Xuan Lv, Qi Kong, Xin Ma
doaj   +1 more source